Healthy adults
Conditions
Interventions
None listed
Sponsors
Nagaoka Co., Ltd.
Evaluation Center of Health and Nutrition Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants (P): Healthy adults (excluding pregnant and lactating women) with a BMI of 23 or higher and less than 30, who do not fall outside the scope of subjects eligible for Food for Specified Health Uses. Intervention (I): Oral intake of test food containing oenothein B. Comparison (C): Intake of placebo (control) food not containing oenothein B. Outcomes (O): Reduction in visceral fat, body weight, and BMI. Study Design (S): Randomized double-blind placebo-controlled trial (RCT) with parallel-group comparison or crossover comparison. Publication format: Peer-reviewed original articles, systematic reviews, or meta-analysis reports only. However, results published in clinical trial registration databases are included. Unpeer-reviewed reports are limited to those with detailed content, such as doctoral theses or reports similar to statistical white papers issued by public institutions.
Exclusion criteria
Exclusion criteria: Reports that are not clinical trials involving humans. Reports that do not meet the above PICOS criteria. Reports that do not meet the above report characteristics. Reports without a control group. Reports that did not evaluate the efficacy of oenothein B alone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area Body weight BMI | — |
Countries
Japan
Contacts
Public ContactOffice
Nagaoka Co., Ltd. Research and Development Center
Outcome results
None listed